LMAT - LeMaitre Vascular, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
35.27
0.00 (0.00%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close35.27
Open35.19
Bid32.01 x 100
Ask35.99 x 100
Day's Range34.86 - 35.50
52 Week Range19.82 - 39.88
Volume73,660
Avg. Volume121,409
Market Cap679.473M
Beta0.61
PE Ratio (TTM)45.16
EPS (TTM)0.78
Earnings DateOct 24, 2017 - Oct 30, 2017
Forward Dividend & Yield0.22 (0.62%)
Ex-Dividend Date2017-11-21
1y Target Est33.40
Trade prices are not sourced from all markets
  • GlobeNewswire8 days ago

    LeMaitre Vascular Will Announce Fourth Quarter 2017 Earnings Results on February 21, 2018

    BURLINGTON, Mass., Feb. 09, 2018-- LeMaitre Vascular, Inc. announced today that it will release its fourth quarter 2017 financial results on Wednesday, February 21, 2018, after the market close. The company ...

  • 3 Top Healthcare Stocks to Buy Right Now
    Motley Foollast month

    3 Top Healthcare Stocks to Buy Right Now

    The S&P 500's top-performing stock last year and two under-the-radar small caps could be worth a closer look.

  • GlobeNewswirelast month

    LeMaitre Vascular to Present at the Needham Growth Conference on Thursday, January 18, 2018

    BURLINGTON, Mass., Jan. 11, 2018-- LeMaitre Vascular, Inc. announced today that JJ Pellegrino, Chief Financial Officer, will present at Needham & Company’ s 20 th Annual Growth Conference on Thursday, ...

  • LeMaitre Vascular, Inc. :LMAT-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017
    Capital Cube2 months ago

    LeMaitre Vascular, Inc. :LMAT-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017

    Categories: Yahoo FinanceGet free summary analysis LeMaitre Vascular, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of LeMaitre Vascular, Inc. – Endologix, Inc. and Teleflex Incorporated (ELGX-US and TFX-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 24.82 million, Net ... Read more (Read more...)

  • Should You Buy LeMaitre Vascular Inc (LMAT) Now?
    Simply Wall St.3 months ago

    Should You Buy LeMaitre Vascular Inc (LMAT) Now?

    LeMaitre Vascular Inc (NASDAQ:LMAT), a healthcare equipment and supplies company based in United States, saw a double-digit share price rise of over 10% in the past couple of months onRead More...

  • 3 Unknown, but Amazing, Dividend Stocks
    Motley Fool3 months ago

    3 Unknown, but Amazing, Dividend Stocks

    Looking for a few little-known income gems? Check out these three businesses.

  • Thomson Reuters StreetEvents4 months ago

    Edited Transcript of LMAT earnings conference call or presentation 26-Oct-17 9:00pm GMT

    Q3 2017 LeMaitre Vascular Inc Earnings Call

  • Capital Cube4 months ago

    LeMaitre Vascular, Inc. – Value Analysis (NASDAQ:LMAT) : October 31, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives LeMaitre Vascular, Inc. a score of 81. Our analysis is based on comparing LeMaitre Vascular, Inc. with the following peers – AngioDynamics, Inc., Endologix, Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Cardiovascular Systems, Inc., C. R. Bard, Inc., Baxter International Inc. and Teleflex Incorporated (ANGO-US, ELGX-US, BSX-US, ... Read more (Read more...)

  • Capital Cube4 months ago

    ETFs with exposure to LeMaitre Vascular, Inc. : October 30, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to LeMaitre Vascular, Inc. Here are 5 ETFs with the largest exposure to LMAT-US. Comparing the performance and risk of LeMaitre Vascular, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • LeMaitre Vascular, Inc. breached its 50 day moving average in a Bearish Manner : LMAT-US : October 30, 2017
    Capital Cube4 months ago

    LeMaitre Vascular, Inc. breached its 50 day moving average in a Bearish Manner : LMAT-US : October 30, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for LeMaitre Vascular, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)

  • Why LeMaitre Vascular Inc. Is Plunging Today
    Motley Fool4 months ago

    Why LeMaitre Vascular Inc. Is Plunging Today

    Traders flee after the company reports lower-than-expected quarterly revenue and shares disappointing guidance. Does this drop represent a buying opportunity?

  • Associated Press4 months ago

    LeMaitre beats 3Q profit forecasts

    On a per-share basis, the Burlington, Massachusetts-based company said it had profit of 25 cents. The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...

  • ACCESSWIRE4 months ago

    LeMaitre Vascular, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / October 26, 2017 / LeMaitre Vascular, Inc. (NASDAQ: LMAT ) will be discussing their earnings results in their Q3 Earnings Call to be held on October 26, 2017 at 5:00 PM Eastern ...

  • Capital Cube5 months ago

    ETFs with exposure to LeMaitre Vascular, Inc. : September 28, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to LeMaitre Vascular, Inc. Here are 5 ETFs with the largest exposure to LMAT-US. Comparing the performance and risk of LeMaitre Vascular, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Stocks With Rising Relative Strength: Penumbra
    Investor's Business Daily5 months ago

    Stocks With Rising Relative Strength: Penumbra

    A Relative Strength Rating upgrade for Penumbra shows improving technical performance. Will it continue?

  • 5 MedTech Stocks to Pick for Stellar Returns
    Zacks5 months ago

    5 MedTech Stocks to Pick for Stellar Returns

    While the MedTech industry has been grappling with multiple issues, these stocks with high growth potential can be great bets.

  • 3 Dividend Healthcare Stocks
    Motley Fool5 months ago

    3 Dividend Healthcare Stocks

    Looking for income from the healthcare sector? Here's why you should check out Gilead Sciences, Allergan, and LeMaitre Vascular.

  • Capital Cube5 months ago

    ETFs with exposure to LeMaitre Vascular, Inc. : September 14, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to LeMaitre Vascular, Inc. Here are 5 ETFs with the largest exposure to LMAT-US. Comparing the performance and risk of LeMaitre Vascular, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • LeMaitre Vascular, Inc. :LMAT-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017
    Capital Cube5 months ago

    LeMaitre Vascular, Inc. :LMAT-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017

    Categories: Yahoo FinanceGet free summary analysis LeMaitre Vascular, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of LeMaitre Vascular, Inc. – Endologix, Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Cardiovascular Systems, Inc., C. R. Bard, Inc., Baxter International Inc. and Teleflex Incorporated (ELGX-US, BSX-US, EW-US, ... Read more (Read more...)

  • 5 Top-Ranked MedTech Growth Stocks for Solid Returns
    Zacks5 months ago

    5 Top-Ranked MedTech Growth Stocks for Solid Returns

    Despite the ongoing turmoil in the MedTech industry, these stocks with high growth potential can be great bets for investors.

  • Forget Abbott, Buy These 4 High-Growth MedTech Stocks Instead
    Zacks5 months ago

    Forget Abbott, Buy These 4 High-Growth MedTech Stocks Instead

    The share price performance of Abbott Laboratories (ABT) has been disappointing over the last three years. Of the prime issues plaguing Abbott, foreign exchange is a major one.